Rangering i aksjer
#27207
NaviFUS Corporation operates within the medical device sector, specializing in... NaviFUS Corporation operates within the medical device sector, specializing in the development and commercialization of advanced focused ultrasound (FUS) technologies tailored for neurological applications. The company's primary offering is NaviFUS, a sophisticated transcranial FUS system precisely guided by neuronavigation. This innovative system is engineered to deliver concentrated energy to deep brain regions, supporting a range of clinical interventions such as enhanced drug delivery, neuromodulation, and immuno-stimulation. Additionally, NaviFUS Corp. provides NAVIRFA, a sophisticated navigation system that utilizes optical three-dimensional surgical tracking technology. Its purpose is to accurately monitor the exact placement of needle tips during various ultrasonic interventional procedures. Founded in 2015, the company's headquarters are located in Taipei, Taiwan.
Handel NaviFUS Corp. (6872)
Pris 6872 pris med markedsverdi på B
Markedsverdi av NaviFUS Corp.(6872)
Markedsverdi: $34.42M
Per August 2026 har NaviFUS Corp. en markedsverdi på $34.42M. Dette gjør NaviFUS Corp. til det 27207th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for NaviFUS Corp. fra 2022 til 2026
6872 sammenlignet med topp 5 mest populære stocks
| Pris på 6872 |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.301T
|
+15,398,595.30%
|
|
|
|
|
$4.634T
|
+13,461,001.64%
|
|
|
|
|
$4.143T
|
+12,035,004.25%
|
|
|
|
|
$3.589T
|
+10,426,806.99%
|
|
|
|
|
$2.857T
|
+8,299,159.98%
|
